A citation-based method for searching scientific literature

R C Chambers, P Leoni, O P Blanc-Brude, D E Wembridge, G J Laurent. J Biol Chem 2000
Times Cited: 196







List of co-cited articles
1063 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.
R C Chambers, K Dabbagh, R J McAnulty, A J Gray, O P Blanc-Brude, G J Laurent. Biochem J 1998
124
35

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
D C Howell, N R Goldsack, R P Marshall, R J McAnulty, R Starke, G Purdy, G J Laurent, R C Chambers. Am J Pathol 2001
134
29

Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
David C J Howell, Robin H Johns, Joseph A Lasky, Bin Shan, Chris J Scotton, Geoffrey J Laurent, Rachel C Chambers. Am J Pathol 2005
158
29


Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.
R Gisli Jenkins, Xiao Su, George Su, Christopher J Scotton, Eric Camerer, Geoffrey J Laurent, George E Davis, Rachel C Chambers, Michael A Matthay, Dean Sheppard. J Clin Invest 2006
230
20

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, Paul F Mercer, Y C Gary Lee, Naftali Kaminski, John Morser, Joseph M Post, Toby M Maher, Andrew G Nicholson,[...]. J Clin Invest 2009
220
20

Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.
Olivier P Blanc-Brude, Fabienne Archer, Patricia Leoni, Claudia Derian, Steven Bolsover, Geoffrey J Laurent, Rachel C Chambers. Exp Cell Res 2005
75
25


Anticoagulant therapy for idiopathic pulmonary fibrosis.
Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki. Chest 2005
294
18



Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis.
S Imokawa, A Sato, H Hayakawa, M Kotani, T Urano, A Takada. Am J Respir Crit Care Med 1997
108
16

Role of thrombin in pulmonary fibrosis.
N A Hernández-Rodríguez, A D Cambrey, N K Harrison, R C Chambers, A J Gray, A M Southcott, R M duBois, C M Black, M F Scully, R J McAnulty. Lancet 1995
109
15

PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation.
Stefano Fiorucci, Elisabetta Antonelli, Eleonora Distrutti, Beatrice Severino, Roviezzo Fiorentina, Monia Baldoni, Giuseppe Caliendo, Vincenzo Santagada, Antonio Morelli, Giuseppe Cirino. Hepatology 2004
123
14

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
N Hattori, J L Degen, T H Sisson, H Liu, B B Moore, R G Pandrangi, R H Simon, A F Drew. J Clin Invest 2000
215
13

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
H Yasui, E C Gabazza, S Tamaki, T Kobayashi, O Hataji, H Yuda, S Shimizu, K Suzuki, Y Adachi, O Taguchi. Am J Respir Crit Care Med 2001
118
12


Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
Andreas Günther, Norbert Lübke, Monika Ermert, Ralph T Schermuly, Norbert Weissmann, Andreas Breithecker, Philipp Markart, Clemens Ruppert, Karin Quanz, Leander Ermert,[...]. Am J Respir Crit Care Med 2003
127
12

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Richard M Silver. Arthritis Rheum 2009
68
17

Proteinase-activated receptors.
S R Macfarlane, M J Seatter, T Kanke, G D Hunter, R Plevin. Pharmacol Rev 2001
950
10


Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts.
Galina S Bogatkevich, Estella Gustilo, Jim C Oates, Carol Feghali-Bostwick, Russell A Harley, Richard M Silver, Anna Ludwicka-Bradley. Am J Physiol Lung Cell Mol Physiol 2005
52
19


Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
I Kotani, A Sato, H Hayakawa, T Urano, Y Takada, A Takada. Thromb Res 1995
144
10


A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
295
10

A role for thrombin in liver fibrosis.
J Gillibert Duplantier, L Dubuisson, N Senant, G Freyburger, I Laurendeau, J-M Herbert, A Desmoulière, J Rosenbaum. Gut 2004
61
14

Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF.
O P Blanc-Brude, R C Chambers, P Leoni, W A Dik, G J Laurent. Am J Physiol Cell Physiol 2001
41
21




Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells.
Nithiananthan Asokananthan, Peter T Graham, Joshua Fink, Darryl A Knight, Anthony J Bakker, Andrew S McWilliam, Philip J Thompson, Geoffrey A Stewart. J Immunol 2002
305
8

Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation.
A Ludwicka-Bradley, E Tourkina, S Suzuki, E Tyson, M Bonner, J W Fenton, S Hoffman, R M Silver. Am J Respir Cell Mol Biol 2000
58
13

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
A Holmes, D J Abraham, S Sa, X Shiwen, C M Black, A Leask. J Biol Chem 2001
340
8


Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
8

Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury.
F Marra, R DeFranco, C Grappone, S Milani, M Pinzani, G Pellegrini, G Laffi, P Gentilini. Hepatology 1998
80
8


Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.
M A Cunningham, E Rondeau, X Chen, S R Coughlin, S R Holdsworth, P G Tipping. J Exp Med 2000
158
7

Protease-activated receptor 3 is a second thrombin receptor in humans.
H Ishihara, A J Connolly, D Zeng, M L Kahn, Y W Zheng, C Timmons, T Tram, S R Coughlin. Nature 1997
750
7

'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
Nicole C Kaneider, Andrew J Leger, Anika Agarwal, Nga Nguyen, George Perides, Claudia Derian, Lidija Covic, Athan Kuliopulos. Nat Immunol 2007
173
7

Protease-activated receptors: contribution to physiology and disease.
Valeria S Ossovskaya, Nigel W Bunnett. Physiol Rev 2004
811
7



High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Maurits Demedts, Juergen Behr, Roland Buhl, Ulrich Costabel, Richard Dekhuijzen, Henk M Jansen, William MacNee, Michiel Thomeer, Benoit Wallaert, François Laurent,[...]. N Engl J Med 2005
643
7

Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.
Paul F Mercer, Robin H Johns, Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, David C J Howell, Robin J McAnulty, Anuk Das, Andrew J Thorley, Terry D Tetley,[...]. Am J Respir Crit Care Med 2009
80
8

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Galina S Bogatkevich, Anna Ludwicka-Bradley, Paul J Nietert, Tanjina Akter, Joanne van Ryn, Richard M Silver. Arthritis Rheum 2011
76
9



PAR3 is a cofactor for PAR4 activation by thrombin.
M Nakanishi-Matsui, Y W Zheng, D J Sulciner, E J Weiss, M J Ludeman, S R Coughlin. Nature 2000
410
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.